Found 43 matching trials
An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy PHASE2 The primary objective of study Part A is to assess the safety of talacotuzu...
Show More Location
Multiple Locations
Learn More & Join Trial
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old PHASE3 The study will include newly-diagnosed AML patients, not suffering acute pr...
Show More Location
Weill Cornell Medicine
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants. PHASE1 This is a Phase I/II clinical study to determine the maximum tolerated dose...
Show More Learn More & Join Trial
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL PHASE2 This is a prospective, open-label, multicenter, randomized controlled study...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects PHASE2 The purpose of this study is to provide data on the activity of a standard ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma PHASE4 To explore the safety, tolerability, and clinical effects of decitabine com...
Show More Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL PHASE2 The purpose of this study is to compare the efficacy and safety of genotype...
Show More Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Learn More & Join Trial
Genotype-guided Treatment in DLBCL PHASE3 A multicenter, prospective, randomized, open-label, controlled trial to eva...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia PHASE2 This phase II trial studies the effect of ascorbic acid and combination che...
Show More Location
Mayo Clinic Health Systems-Mankato
Learn More & Join Trial
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN PHASE2 This is a single-center randomized phase 2 open-label clinical trial....
Location
Virginia Commonwealth University
Learn More & Join Trial